Related Experiment Video
Updated: Jul 9, 2025
08:33
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
1.2K
Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case Report
1Pain Division Mountain View Headache and Spine Institute.
Health Psychology Research
|November 30, 2023
Summary
Intravenous ketamine infusion effectively manages fibromyalgia pain. Higher doses, frequent administration, and longer infusion times may enhance therapeutic benefits for chronic pain patients.
Area of Science:
- Neurology
- Pain Management
- Pharmacology
Background:
- Fibromyalgia is a chronic pain disorder with unclear causes.
- Ketamine is used for chronic pain, but dosing protocols vary.
- Standardized ketamine dosing for fibromyalgia is needed.
Purpose of the Study:
- To present a case study on ketamine dosing for fibromyalgia.
- To contribute to developing consensus on ketamine protocols for fibromyalgia.
Main Methods:
- A 60-year-old female with fibromyalgia received 9 IV ketamine sessions.
- Initial dose escalated from 50 mg to 240 mg.
- Maintenance therapy included two monthly infusions.
Main Results:
- Patient reported over 50% pain relief after initial treatment.
- Successful long-term pain management achieved with maintenance infusions.
Conclusions:
- IV ketamine is effective for fibromyalgia pain management.
- Increased total dose, frequency, and duration may optimize ketamine therapy.
